Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

The method effectively predicts new drug uses, including potential COVID-19 treatments.

The review suggests doctors should carefully weigh risks and benefits of off-label drug use, involve patients in decisions, and calls for better regulations and monitoring.

Future work on macrolide antibiotic analysis will aim to enhance selectivity, sensitivity, and efficiency using advanced chromatographic methods.

European patent law now allows patents for new uses and dosages of known drugs, but protection scope is unclear.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

The peer review highlighted the need for clearer data handling, questioned the study's validity, and recognized improvements from the original version.

Current methods for assessing bioequivalence of topical drugs are limited and lack standardization.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Drug repurposing shows promise for treating many medical conditions.

Abolishing medical indication patents could hinder innovation in medicine.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Big chain pharmacies in Pennsylvania charge significantly more for generic BPH medications than independent pharmacies, but independent pharmacies have more regional price variation.

Multiple treatment comparison meta-analyses help doctors make better decisions by comparing different interventions.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

BPH management needs better long-term studies and prevention strategies.

The EVInews database provides significantly higher quality information than web-based sources for pharmacists.

Current drug safety systems fail to detect long-term side effects, leading to preventable health issues.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Repurposing existing drugs can quickly and cheaply find new treatments for unmet medical needs.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

Some people pay $240 for medication that costs $9 due to drug industry tactics and complicated healthcare policies.

Home-use treatment for severe alopecia areata is as effective as office-use but costs half as much.